Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
Corresponding Author
Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Italy
Correspondence
Prof. Lorenzo A Calò MD, PhD, Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Via Giustiniani, 2, 35128 PADOVA ITALY.
Email: renzcalo@unipd.it
Search for more papers by this author
Comments (0)